The effect of L-arginine in experimental colitis

Annals of Gastroenterology

Volumn 17, Issue 3, 2004, Pages 270-275

  Fotiadis, Constantinos ^a,c   Papanicolaou, I ^a   Xekouki, P ^a   Papandreou, I ^a   Aroni, A ^b   Poussios, D ^a   Athanassiades, D ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c NONE   (Greece)

Author keywords

IBD; Inflammatory bowel disease; Ischemic colitis; L Arginine; Nitric oxide

Indexed keywords

ALANINE AMINOTRANSFERASE; ARGININE; ASPARTATE AMINOTRANSFERASE; GLUCOSE; HEMOGLOBIN; MALONALDEHYDE; NITRIC OXIDE; TRINITROBENZENESULFONIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATROPHY; BLOOD CELL COUNT; BLOOD SAMPLING; COLON RESECTION; CONTROLLED STUDY; DISEASE SEVERITY; EDEMA; EOSINOPHIL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HISTOPATHOLOGY; INTESTINE VILLUS; ISCHEMIC COLITIS; LAMINA PROPRIA; LEUKOCYTE COUNT; LYMPHOCYTE; MACROPHAGE; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; NEUTROPHIL; NONHUMAN; RAT; STATISTICAL ANALYSIS;

EID: 34548525252     PISSN: 11087471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. De Dombai FT. The epidemiology of IBD. Some international data and reflections. FT De Dombai, J Myren, IAD Bouchier, G Watkinson (eds) Oxford Univercity Press, 1986, pp 66-93.
2. Isgar B Harman, Whorwell PJ. Factors preceding relapse of ulcerative colitis. Digestion 1983; 236-238.
3. Zen L, Anderson FH. Seasonal change in the exacerbations of Crohns disease. Scand. J Gastroenterology 1996; 31:79-82.
4. Boughton-Smith NK, Evans Sm, Hawkkey CJ, et al. NO synthase activity in ulcerative colitis and Crohn's disease. Lancet 1993; 342:338-340.
5. Southey A, Tanaka S, Murakami T, et al. Pathophysiological role of nitric oxide in rat experimental colitis. Int. Jimmunopharmacology 1997; 19:669-676.
6. Torres MI, Garcia-Martin M, Nieto N, Gil A, Rios A. Digestive Diseases and Sciences, Vol. 44, 1999, pp 2523-2529.
7. Barbul A. Arginine and immune function. Nutrition 1990; 6:53-58.
8. Barbul A, Rettura G, Levenson SM, Seifter E. Arginine: A thymotrophic and wound healing promoting agent. Surgical Forum 1977; 28:101-103.
9. Barbul A, Wasserkrug HL, Seifer E, Rettura G, Levenson SM. Immunostimulatory effects of arginine in normal and injured rats. J Surg Res 1988; 29:228-35.
10. Madden HP, Breslin RJ, Wasserkrug HL, Efron G. Stimulation of T-cell immunity by arginine enhances survival in peritonitis. J Surg Res 1988; 44:658-663.
11. Barbul A, Wasserkrug HL, Yoshimura N, Tao R. High arginine levels in intravenous hyperlimentation abrogate post traumatic imm.suppression. J Surg Res 1984; 36:620-624.
12. Saito H, Trocki O, Wang SL, Joffe SN, Alexander JW. Metabolic and immune effects of dietary arginine supplementation after burn. Arch Surg 1987; 122:784-789.
13. Tachibana K, Mukai Y, Hiraoka I, Moriguchi S, Takama S, Kishino Y. Evaluation of the effect of arginine enriched amino acid solution on tumor growth. JPEN J Parenteral Nutr 1985; 9:428-434.
14. Moncada S, Higgs A. The L-Arginine-nitric oxide pathway. N Engl J Med 1993; 329:2002-2012.
15. Kaplan SS, Billiar T, Curran RD, Zdiarski UE. Inhibition of chemotaxis. Blood 1989; 74:1885-1887.
16. Sherman MP, Loro ML, Wong VZ, Tashkin DP. Cytokine and pneum.Carinii induced L-arg oxidation by murine and human pulmonary alveolar macrophages. J Protozool 1991; 38:234-265.
17. Kirk SJ, Regan MC, Barbul A. Cloned murine T-lymphocytes synthesize a molecule with the biological characteristics of NO. Biochem-Biophys Res Commun 1990; 173: 660-665.
18. Armstrong AM, Campell GR, Gannon C, et al. Oral administration of inducible NO synthase inhibitors. Scand. J Gastroenterol 2000; 35:832-838
19. Mane' J, Fernandez-Banares F, Ojanguren I, et al. Effect of L-arginine on experimental colitis. Clinical Nutrition 2001; 205:415-442
20. Neilly PJD, Kirk SJ, Gardiner KR, et al. Manipulation of the L-arg - NO pathway in experimental colitis. British Journal of Surgery 1995; 82:1188-1191.
21. Elson CO, Balfour R, Sartor G, Tennyson S, Robert H. Experimental models of inflammatory bowel disease. Gastroenterology 1995; 109:1344-1367.
22. Stenson WF. Animal models of colitis. Gastroenterology 1995; 11:310-315.
23. Higa A, McKnight GW, Wallace JL. Attenuation of epithelial injury in acute experimental colitis. by immunoglobulators. Eur J Pharmacol. 1993; 39:171-176.
24. Neurath MF, Fuss I, Kelsall BL, Presky DH, Waegell W. Experimental granulomatous colitis in mice is abrogated by induction. Of TGF-beta-mediated tolerance. J Exp Med 1996; 183:2605-2616.
25. Nakamura H, Tsukada M, Onomura T, et al. The effect of aminoguanidine an iNOS inhibitor in experimental colitis. Gastroenterology 1998; 114:G4289.
26. Rachmilewitz D. Peroxynitrite induced experimental colitis. Gastroenterology 1993; 105:1681-1685.
27. Rodeberg DA, Chaet MC, Baa RC, Arkovitz MS, Garcia VF. Nitric oxide: An overview. Am J Surg 1995; 170:292-303.
28. McCafferty DM, Mudgett JS, Swain MG, Kubes P. Inducible NO synthase plays a critical role in resolving intestinal. Inflammation. Gastroenterology 1997; 112:1022-1027.